José Juan Jiménez-Moleón
University of Granada
179 Papers
1K Citations
José Juan Jiménez-Moleón is an academic researcher from University of Granada. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 31, co-authored 141 publications. Previous affiliations of José Juan Jiménez-Moleón include Carlos III Health Institute.
Chat about Author
Papers
Drug-related problems in older people after hospital discharge and interventions to reduce them.
Marta García-Caballos,Marta García-Caballos,Francisco Ramos-Diaz,Francisco Ramos-Diaz,José Juan Jiménez-Moleón,Aurora Bueno-Cavanillas +5 more
TL;DR: It is not possible to estimate the frequency of drug-related problem through a review of selected articles or to evaluate the efficacy of the proposed interventions, so more research is needed in this field to reduce uncertainty and generate evidence-based recommendations for physicians.
A systematic review of the efficacy of intravesical electromotive drug administration therapy for non-muscle invasive bladder cancer.
M Teresa Melgarejo-Segura,Ana Morales-Martínez,Y. Yáñez-Castillo,Miguel Angel Arrabal-Polo,P. Gómez-Lechuga,Manuel Pareja-Vilchez,José Juan Jiménez-Moleón,M. A. Martin +7 more
- 01 Oct 2022
TL;DR: In this paper , the effectiveness of mitomycin C (MMC) applied with an electromotive drug administration device (EMDA) in the treatment of patients with non-muscle invasive bladder tumors was analyzed.
Identification of novel prostate cancer genes in patients stratified by Gleason classification: Role of antitumoral genes
Elisa Díaz de la Guardia-Bolívar,Rocío Barrios-Rodríguez,Igor Zwir,José Juan Jiménez-Moleón,Coral del Val +4 more
TL;DR: Differential gene expression analyses over paired samples comparing primary PCa tissue against healthy prostatic tissue of PCa patients show that this approach is a serious alternative to overcome patient heterogeneity, and points to CGREF1, UNC5A, C16orf74, LGR6, IGSf1, QPRT and CA14 as possible new early markers in PCa.
Predictors of Long-Term Mortality in Older People With Hip Fracture
TL;DR: Change of residence is the only potentially modifiable risk factor, independent of the following other traditional risk factors that were found: age, sex, health status, and prefracture functional level.